These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 28286407)

  • 1. Pulmonary Hypertension Associated with Idiopathic Pulmonary Fibrosis: Current and Future Perspectives.
    Collum SD; Amione-Guerra J; Cruz-Solbes AS; DiFrancesco A; Hernandez AM; Hanmandlu A; Youker K; Guha A; Karmouty-Quintana H
    Can Respir J; 2017; 2017():1430350. PubMed ID: 28286407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary hypertension in chronic lung diseases.
    Seeger W; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs S; Martinez FJ; Semigran MJ; Simonneau G; Wells AU; Vachiéry JL
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D109-16. PubMed ID: 24355635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary hypertension associated with chronic obstructive lung disease and idiopathic pulmonary fibrosis.
    Adir Y; Harari S
    Curr Opin Pulm Med; 2014 Sep; 20(5):414-20. PubMed ID: 25046428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct differences in gene expression patterns in pulmonary arteries of patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis with pulmonary hypertension.
    Hoffmann J; Wilhelm J; Marsh LM; Ghanim B; Klepetko W; Kovacs G; Olschewski H; Olschewski A; Kwapiszewska G
    Am J Respir Crit Care Med; 2014 Jul; 190(1):98-111. PubMed ID: 24918967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary hypertension in idiopathic pulmonary fibrosis: a review.
    Corte TJ; Wort SJ; Wells AU
    Sarcoidosis Vasc Diffuse Lung Dis; 2009 Jul; 26(1):7-19. PubMed ID: 19960783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Right Ventricular Structure and Function in Idiopathic Pulmonary Fibrosis with or without Pulmonary Hypertension.
    D'Andrea A; Stanziola A; Di Palma E; Martino M; D'Alto M; Dellegrottaglie S; Cocchia R; Riegler L; Betancourt Cordido MV; Lanza M; Maglione M; Diana V; Calabrò R; Russo MG; Vannan M; Bossone E
    Echocardiography; 2016 Jan; 33(1):57-65. PubMed ID: 26096076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary hypertension in idiopathic pulmonary fibrosis: a review.
    Pitsiou G; Papakosta D; Bouros D
    Respiration; 2011; 82(3):294-304. PubMed ID: 21677422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary hypertension and idiopathic pulmonary fibrosis: a dastardly duo.
    Smith JS; Gorbett D; Mueller J; Perez R; Daniels CJ
    Am J Med Sci; 2013 Sep; 346(3):221-5. PubMed ID: 23313949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary hypertension associated with lung diseases and hypoxemia.
    Cuttica MJ
    Heart Fail Rev; 2016 May; 21(3):299-308. PubMed ID: 27086030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary hypertension and idiopathic pulmonary fibrosis: a tale of angiogenesis, apoptosis, and growth factors.
    Farkas L; Gauldie J; Voelkel NF; Kolb M
    Am J Respir Cell Mol Biol; 2011 Jul; 45(1):1-15. PubMed ID: 21057104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic pulmonary fibrosis is associated with increased impedance measures of reflux compared to non-fibrotic disease among pre-lung transplant patients.
    Gavini S; Finn RT; Lo WK; Goldberg HJ; Burakoff R; Feldman N; Chan WW
    Neurogastroenterol Motil; 2015 Sep; 27(9):1326-32. PubMed ID: 26176338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review.
    Raghu G; Amatto VC; Behr J; Stowasser S
    Eur Respir J; 2015 Oct; 46(4):1113-30. PubMed ID: 26424523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary hypertension in idiopathic pulmonary fibrosis does not influence six-minute walk distance: results from a retrospective study.
    Harari S; Caminati A; Cassandro R; Conti S; Madotto F; Luisi F; Cesana G
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jan; 31(4):297-305. PubMed ID: 25591141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology of Pulmonary Hypertension in Chronic Parenchymal Lung Disease.
    Singh I; Ma KC; Berlin DA
    Am J Med; 2016 Apr; 129(4):366-71. PubMed ID: 26706386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary hypertension in idiopathic pulmonary fibrosis: prevalence and clinical progress.
    Castria D; Refini RM; Bargagli E; Mezzasalma F; Pierli C; Rottoli P
    Int J Immunopathol Pharmacol; 2012; 25(3):681-9. PubMed ID: 23058018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary hypertension in idiopathic pulmonary fibrosis with mild-to-moderate restriction.
    Raghu G; Nathan SD; Behr J; Brown KK; Egan JJ; Kawut SM; Flaherty KR; Martinez FJ; Wells AU; Shao L; Zhou H; Henig N; Szwarcberg J; Gillies H; Montgomery AB; O'Riordan TG
    Eur Respir J; 2015 Nov; 46(5):1370-7. PubMed ID: 26250495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Echocardiography, 6-minute walk distance, and distance-saturation product as predictors of pulmonary arterial hypertension in idiopathic pulmonary fibrosis.
    Modrykamien AM; Gudavalli R; McCarthy K; Parambil J
    Respir Care; 2010 May; 55(5):584-8. PubMed ID: 20420729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examining prevalence and predictors of pulmonary hypertension in adults with idiopathic pulmonary fibrosis: a population-based analysis in the United States.
    Desai R; Katukuri N; Kanagala SG; Ghadge N; James A; Tajdin B; Nalla A; Vutukuru SD; Kotharu DM; Kadiyala A; Vyas A; Prajjwal P; Ogbu I
    J Med Life; 2024 Jan; 17(1):35-40. PubMed ID: 38737661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise capacity in idiopathic pulmonary fibrosis: the effect of pulmonary hypertension.
    Boutou AK; Pitsiou GG; Trigonis I; Papakosta D; Kontou PK; Chavouzis N; Nakou C; Argyropoulou P; Wasserman K; Stanopoulos I
    Respirology; 2011 Apr; 16(3):451-8. PubMed ID: 21122030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of pulmonary hypertension in idiopathic pulmonary fibrosis: shortfall in efficacy or trial design?
    Nathan SD; King CS
    Drug Des Devel Ther; 2014; 8():875-85. PubMed ID: 25061279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.